cyclic lipopeptide antibiotic
Daptomycin
Answer
Daptomycin is authorised or registered in the US, the EU, the UK, Canada, Australia, Switzerland, Brazil, Serbia, Singapore and Turkey: 10 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 132 registered trials, 11 of them running. Brand names on the FDA label register: Daptomycin, Daptomycin In Sodium Chloride and Dapzura Rt.
RegulatorTrial register10 regulators' registers, read 2026-09-03 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
132 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 40 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 96 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Authorised | EMA, ema | 2026-10-03 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Registered | TGA, au-artg | 2026-10-03 |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-10-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Authorised | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Registered | HSA, sg-hsa | 2026-09-03 |
| Turkey | Ruhsatli | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
CHANGE ALERTS
Get an email when this changes
One email when the status of Daptomycin changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 132 trials
| NCT00967941 | Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis completed · register updated 2026-09-14 |
|---|---|
| NCT06637332 | Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia currently recruiting participants · register updated 2026-09-09 |
| NCT07376889 | Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia currently recruiting participants · register updated 2026-08-25 |
| 2024-514952-34-00 | Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during no status recorded · register updated 2026-07-30 |
| 2023-508442-18-00 | Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material i no status recorded · register updated 2026-07-21 |
| 2026-526149-91-00 | Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci no status recorded · register updated 2026-06-30 |
| NCT07058415 | Impact of Three Probabilistic Antibiotic Therapy on Digestive Microbiota and Colonization With Multi-resistant Bacteria not yet recruiting participants · register updated 2026-06-22 |
| 2024-519186-21-01 | Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia:
A randomized, non-b no status recorded · register updated 2026-06-18 |
| 2023-503582-35-00 | Staphylococcus aureus Network Adaptive Platform trial (SNAP) no status recorded · register updated 2026-05-06 |
| NCT05137119 | Staphylococcus Aureus Network Adaptive Platform Trial currently recruiting participants · register updated 2026-05-06 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.